182 related articles for article (PubMed ID: 19756183)
41. Vogt-Koyanagi-Harada disease-like uveitis after drug therapy including BRAF/MEK inhibitors in melanoma patients with HLA-DRB1*04.
Amagai R; Fujimura T; Yamazaki E; Takahashi M; Tamabuchi E; Kambayashi Y; Hashimoto A; Hashimoto K; Asano Y
J Dermatol; 2024 Jun; 51(6):854-857. PubMed ID: 38111371
[TBL] [Abstract][Full Text] [Related]
42. Vogt-Koyanagi-Harada-like Syndrome Complicating Pembrolizumab Treatment for Metastatic Melanoma.
Bricout M; Petre A; Amini-Adle M; Bezza W; Seve P; Kodjikian L; Dalle S; Thomas L
J Immunother; 2017; 40(2):77-82. PubMed ID: 28166182
[TBL] [Abstract][Full Text] [Related]
43. HLA-DRB1 association in Saudi rheumatoid arthritis patients.
Al-Swailem R; Al-Rayes H; Sobki S; Arfin M; Tariq M
Rheumatol Int; 2006 Sep; 26(11):1019-24. PubMed ID: 16673133
[TBL] [Abstract][Full Text] [Related]
44. Variants in IL23R-C1orf141 and ADO-ZNF365-EGR2 are associated with susceptibility to Vogt-Koyanagi-Harada disease in Japanese population.
Sakono T; Meguro A; Takeuchi M; Yamane T; Teshigawara T; Kitaichi N; Horie Y; Namba K; Ohno S; Nakao K; Sakamoto T; Sakai T; Nakano T; Keino H; Okada AA; Takeda A; Ito T; Mashimo H; Ohguro N; Oono S; Enaida H; Okinami S; Horita N; Ota M; Mizuki N
PLoS One; 2020; 15(5):e0233464. PubMed ID: 32437414
[TBL] [Abstract][Full Text] [Related]
45. Tyrosinase epitope recognized by an HLA-DR-restricted T-cell line from a Vogt-Koyanagi-Harada disease patient.
Kobayashi H; Kokubo T; Takahashi M; Sato K; Miyokawa N; Kimura S; Kinouchi R; Katagiri M
Immunogenetics; 1998 Apr; 47(5):398-403. PubMed ID: 9510558
[TBL] [Abstract][Full Text] [Related]
46. Revised diagnostic criteria for vogt-koyanagi-harada disease: considerations on the different disease categories.
da Silva FT; Damico FM; Marin ML; Goldberg AC; Hirata CE; Takiuti PH; Olivalves E; Yamamoto JH
Am J Ophthalmol; 2009 Feb; 147(2):339-345.e5. PubMed ID: 18992868
[TBL] [Abstract][Full Text] [Related]
47. MIF gene polymorphisms confer susceptibility to Vogt-Koyanagi-Harada syndrome in a Han Chinese population.
Zhang C; Liu S; Hou S; Lei B; Zheng X; Xiao X; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7734-8. PubMed ID: 24194192
[TBL] [Abstract][Full Text] [Related]
48. New insights into Vogt-Koyanagi-Harada disease.
Damico FM; Bezerra FT; Silva GC; Gasparin F; Yamamoto JH
Arq Bras Oftalmol; 2009; 72(3):413-20. PubMed ID: 19668980
[TBL] [Abstract][Full Text] [Related]
49. Association between Vogt-Koyanagi-Harada syndrome and HLA-DR1 and -DR4 in Hispanic patients living in southern California.
Weisz JM; Holland GN; Roer LN; Park MS; Yuge AJ; Moorthy RS; Forster DJ; Rao NA; Terasaki PI
Ophthalmology; 1995 Jul; 102(7):1012-5. PubMed ID: 9121744
[TBL] [Abstract][Full Text] [Related]
50. Epigenome-wide association study identifies Vogt-Koyanagi-Harada disease-associated DNA methylation loci in Chinese.
Su G; Du L; Yu H; Li M; Huang R; Yang X; Wang D; Wang Q; Yang P
Exp Eye Res; 2023 Aug; 233():109553. PubMed ID: 37394087
[TBL] [Abstract][Full Text] [Related]
51. Immunogenetic study of sympathetic ophthalmia.
Shindo Y; Ohno S; Usui M; Ideta H; Harada K; Masuda H; Inoko H
Tissue Antigens; 1997 Feb; 49(2):111-5. PubMed ID: 9062965
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of PTPN22 polymorphisms and Vogt-Koyanagi-Harada disease in Japanese patients.
Horie Y; Kitaichi N; Katsuyama Y; Yoshida K; Miura T; Ota M; Asukata Y; Inoko H; Mizuki N; Ishida S; Ohno S
Mol Vis; 2009 Jun; 15():1115-9. PubMed ID: 19503742
[TBL] [Abstract][Full Text] [Related]
53. Uveodermatologic (VKH-like) syndrome in American Akita dogs is associated with an increased frequency of DQA1*00201.
Angles JM; Famula TR; Pedersen NC
Tissue Antigens; 2005 Dec; 66(6):656-65. PubMed ID: 16305682
[TBL] [Abstract][Full Text] [Related]
54. HLA associations and ancestry in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia.
Davis JL; Mittal KK; Freidlin V; Mellow SR; Optican DC; Palestine AG; Nussenblatt RB
Ophthalmology; 1990 Sep; 97(9):1137-42. PubMed ID: 2234843
[TBL] [Abstract][Full Text] [Related]
55. Association of ZC3HAV1 single nucleotide polymorphisms with the susceptibility of Vogt-Koyanagi-Harada Disease.
Wu Q; Zhong Z; Zhou C; Cao Q; Su G; Yang P
BMC Med Genomics; 2023 May; 16(1):113. PubMed ID: 37221558
[TBL] [Abstract][Full Text] [Related]
56. Vogt-Koyanagi-Harada syndrome.
Greco A; Fusconi M; Gallo A; Turchetta R; Marinelli C; Macri GF; De Virgilio A; de Vincentiis M
Autoimmun Rev; 2013 Sep; 12(11):1033-8. PubMed ID: 23567866
[TBL] [Abstract][Full Text] [Related]
57. Vogt-Koyanagi-Harada syndrome associated with cutaneous malignant melanoma: an 11-year follow-up.
Aisenbrey S; Lüke C; Ayertey HD; Grisanti S; Perniok A; Brunner R
Graefes Arch Clin Exp Ophthalmol; 2003 Dec; 241(12):996-9. PubMed ID: 14618342
[TBL] [Abstract][Full Text] [Related]
58. [Incomplete Vogt-Koyanagi-Harada syndrome associated with HLA DRB1*01 in a 4-year-old child: case report].
Lucena DR; Paula JS; Silva GC; Rodrigues Mde L
Arq Bras Oftalmol; 2007; 70(2):340-2. PubMed ID: 17589710
[TBL] [Abstract][Full Text] [Related]
59. CFI-rs7356506 polymorphisms associated with Vogt-Koyanagi-Harada syndrome.
Dai ML; Huang XF; Wang QF; Cai WJ; Jin ZB; Wang Y
Mol Vis; 2016; 22():9-17. PubMed ID: 26900322
[TBL] [Abstract][Full Text] [Related]
60. Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease.
Sugita S; Sagawa K; Mochizuki M; Shichijo S; Itoh K
Int Immunol; 1996 May; 8(5):799-803. PubMed ID: 8671669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
